Four Ways To Draw DDMAC's Ire: In Print, On A Dosing Card, In A Script, And In Person
This article was originally published in The Pink Sheet Daily
Executive Summary
In a series of letters, FDA cites Lilly, Cephalon, Bayer and Amylin for promotional violations.